Bacterial Toxin Research Citations

June 18, 2024

Virology

Gupta, P;Venuti, A;Savoldy, M;Harold, A;Zito, FA;Taverniti, V;Romero-Medina, MC;Galati, L;Sirand, C;Shahzad, N;Shuda, M;Gheit, T;Accardi, R;Tommasino, M;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

), 5 mg/ml insulin (Sigma-Aldrich), 400 ?g/ml hydrocortisone (SIGMA), 10 mg/ml ciprofloxacin hydrochloride (EUROMEDEX) and 20 mg of cholera toxin (List Biological

June 16, 2024

Biorxiv

Bianchimano, P;Leone, P;Smith, E;Gutierrez-Vazquez, C;Wind-andersen, E;Bongers, G;Cristancho, S;Weiner, H;Clemente, J;Tankou, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

's adjuvant (CFA) (BD Difco) per mouse, injected subcutaneously into each flank, followed by intraperitoneal administration of 150 ng of pertussis toxin (List Biological

June 15, 2024

Neuroscience

Xue, Y;Zhang, L;Chu, L;Song, Z;Zhang, B;Su, X;Liu, W;Li, X;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

inal subcutaneous injection. They were also intraperitoneally injected with 500 ng pertussis toxin (List Biological) at the time of immunization and again after 48 h. Thus, an EAE model was established. Mouse body weights were recorded daily post-immunization (PI). Researchers were blinded to experimental conditions and evaluated the EAE severity using an international five-poin

June 15, 2024

Redox Biology

Wu, M;Yu, S;Yan, S;Wu, M;Zhang, L;Chen, S;Shi, D;Liu, S;Fan, Y;Lin, X;Shen, J;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

ubcutaneously injected with 200 ?g MOG35-55 in complete Freund's adjuvant (5 mg/ml, Sigma-Aldrich). Pertussis Toxin (200 ng, List Biological Laboratories) was injected intravenously twice on 0 and 2 days postimmunization (dpi.). The immunized mice were monitored daily with body weight measurement and clinical scores evaluation. EAE symptoms were scored daily as follows: 0, no clinical signs; 0.5, partially limp tail; 1, paralyzed tail; 1.5, hindlimb pare

June 14, 2024

Aims Medical Science

Bandehagh, H;Gozalpour, F;Mousavi, A;Ghavshough, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Injection of MOG35-55, 300 ng of pertussis toxin (List Biological Labs, Campbell, CA, USA) intraperitoneally, into all animals, on days 0 and 2

June 14, 2024

Immunology And Cell Biology

Jordan, MA;Gresle, MM;Gemiarto, AT;Stanley, D;Smith, LD;Laverick, L;Spelman, T;Stankovich, J;Willson, AM;Dinh, XT;Johnson, L;Robertson, K;Reid, CA;Field, J;Butzkueven, H;Baxter, AG;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

tems, Sparks, MD) at day0 between the shoulder blades. The mice also receivedintraperitoneal injection of 250 ng PTX (List BiologicalLaboratories, Campbell, CA) at the day of immunization and2 days later. Disease progression was scored daily from day 8after initial injection, for 30 days. 42 Clinical symptoms of EAEwere scored as follows: 0, no symptoms; 0.5, ta

June 14, 2024

Cell Host & Microbe

Hesser, LA;Puente, AA;Arnold, J;Ionescu, E;Mirmira, A;Talasani, N;Lopez, J;Maccio-Maretto, L;Mimee, M;Nagler, CR;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Cholera Toxin List Biological Laboratories 100B

June 13, 2024

Biochimica Et Biophysica Acta. Molecular Basis Of Disease

Ding, JQ;Zhang, JQ;Zhao, SJ;Jiang, DB;Lu, JR;Yang, SY;Wang, J;Sun, YJ;Huang, YN;Hu, CC;Zhang, XY;Zhang, JX;Liu, TY;Han, CY;Qiao, XP;Guo, J;Zhao, C;Yang, K;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

usly into four sites at the back followed by an intraperitoneal injection of 200 ng pertussis toxin (List Biological Laboratory). The pertussis toxin was given again at day 2 post-immunization (p.i.). After immunization, clinical symptoms of the mice were assessed in a doub

June 11, 2024

Proceedings Of The National Academy Of Sciences Of The United States Of America

Rakebrandt, N;Yassini, N;Kolz, A;Schorer, M;Lambert, K;Goljat, E;Estrada Brull, A;Rauld, C;Balazs, Z;Krauthammer, M;Carballido, JM;Peters, A;Joller, N;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

e immunized with 100 to 200 µg MOG35-55 (BioTrend) emulsified in CFA (Difco Laboratories) containing 5 mg/mL Mycobacterium tuberculosis (Difco Laboratories). Additionally, they received 150 ng PT (List laboratories) on days 0 and 2 after immunization. To induce EAE in RAG1 KO mice, CD4+ T cells were isolated from the spleen and lymph nodes of 2D2 mice. To prepare a single-cell suspension, sple

June 10, 2024

Npj Vaccines

Wolf, MA;O'Hara, JM;Bitzer, GJ;Narayanan, E;Boehm, DT;Bevere, JR;DeJong, MA;Hall, JM;Wong, TY;Falcone, S;Deal, CE;Richards, A;Green, S;Nguyen, B;King, E;Ogega, C;Russo, L;Sen-Kilic, E;Plante, O;Himansu, S;Barbier, M;Carfi, A;Damron, FH;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

te. Serological analysis of B. pertussis specific antibodies Serological responses to vaccination were quantified by ELISA. High-binding microtiter plates were coated with PT (50?ng/well) (PT#180, LIST Biologicals), as described in Boehm et al.20. Plates were also coated with RTX-751 (GenScript), PRN (GenScript), FHA (Native antigen BP-FHA-100), diphtheria toxin (Abcam 188505), tetanus toxin (E ... te. Serological analysis of B. pertussis specific antibodies Serological responses to vaccination were quantified by ELISA. High-binding microtiter plates were coated with PT (50?ng/well) (PT#180, LIST Biologicals), as described in Boehm et al.20. Plates were also coated with RTX-751 (GenScript), PRN (GenScript), FHA (Native antigen BP-FHA-100), diphtheria toxin (Abcam 188505), tetanus toxin (E ... te. Serological analysis of B. pertussis specific antibodies Serological responses to vaccination were quantified by ELISA. High-binding microtiter plates were coated with PT (50?ng/well) (PT#180, LIST Biologicals), as described in Boehm et al.20. Plates were also coated with RTX-751 (GenScript), PRN (GenScript), FHA (Native antigen BP-FHA-100), diphtheria toxin (Abcam 188505), tetanus toxin (E

Bacterial Toxin Research Citations

Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration

Oral vancomycin treatment alters serum levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE

JAK2/STAT3 Pathway Inhibition by AG490 Ameliorates Experimental Autoimmune Encephalomyelitis via Regulation of Th17 Cells and Autophagy

Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis: One sentence summary: Peroxynitrite-mediated Treg IL-2R nitration impacts on multiple sclerosis

Effects of melatonin on the management of multiple sclerosis: A scoping review on animal studies

Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cells

A synbiotic of Anaerostipes caccae and lactulose prevents and treats food allergy in mice

Follicular CD8+ T cells promote immunoglobulin production and demyelination in multiple sclerosis and a murine model

Innate acting memory Th1 cells modulate heterologous diseases

Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice